Table 3 Unadjusted and adjusted correlations between the triglyceride–glucose (TyG) index and cardiometabolic risk factors in the study population (n = 7,404).
Coefficient (r) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
All participants | Boys | Girls | |||||||
Unadjusted | Adjusted | Unadjusted | Adjusted | Unadjusted | Adjusted | ||||
Model 1 | Model 2 | Model 3 | Model 4 | Model 3 | Model 4 | ||||
Sex | 0.051* | – | – | – | – | – | – | – | – |
Age, y | –0.035** | – | – | 0.060* | – | – | − 0.154* | – | – |
BMI SDS | 0.246** | 0.245* | – | 0.276* | 0.282* | – | 0.209* | 0.207* | – |
WC SDS | 0.267* | 0.266* | 0.110* | 0.301* | 0.303* | 0.117* | 0.222* | 0.228* | 0.100* |
SBP, mmHg | 0.141* | 0.169* | 0.104* | 0.187* | 0.178* | 0.089* | 0.113* | 0.128* | 0.082* |
DBP, mmHg | 0.086* | 0.106* | 0.083* | 0.133* | 0.119* | 0.089* | 0.027 | 0.067* | 0.049 |
Glucose, mg/dL | 0.240* | 0.244* | 0.220* | 0.210* | 0.224* | 0.192* | 0.287* | 0.267* | 0.251* |
T-C, mg/dL | 0.273* | 0.266* | 0.241* | 0.292* | 0.308* | 0.268* | 0.239* | 0.238* | 0.227* |
HDL-C, mg/dL | − 0.350* | − 0.365* | − 0.325* | − 0.340* | − 0.336* | − 0.286* | − 0.383* | − 0.382* | − 0.350* |
TG, mg/dL | 0.931* | 0.931* | 0.926* | 0.928* | 0.928* | 0.922* | 0.934* | 0.933* | 0.930* |
LDL-C, mg/dL | 0.098* | 0.091* | 0.051* | 0.105* | 0.115* | 0.055* | 0.078* | 0.079* | 0.057* |